BioNTech SE (BNTX)
88.53
+0.59
(+0.67%)
USD |
NASDAQ |
Apr 23, 16:00
89.30
+0.77
(+0.87%)
After-Hours: 20:00
BioNTech Total Liabilities (Quarterly): 3.051B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.051B |
| September 30, 2023 | 2.477B |
| June 30, 2023 | 2.520B |
| March 31, 2023 | 1.978B |
| December 31, 2022 | 3.457B |
| September 30, 2022 | 4.221B |
| June 30, 2022 | 4.518B |
| March 31, 2022 | 4.899B |
| December 31, 2021 | 4.458B |
| September 30, 2021 | 6.404B |
| Date | Value |
|---|---|
| June 30, 2021 | 4.363B |
| March 31, 2021 | 1.975B |
| December 31, 2020 | 1.165B |
| September 30, 2020 | 612.35M |
| June 30, 2020 | 417.83M |
| March 31, 2020 | 313.32M |
| December 31, 2019 | 340.71M |
| September 30, 2019 | 352.30M |
| June 30, 2019 | 384.17M |
| December 31, 2018 | 441.53M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
313.32M
Minimum
Mar 2020
6.404B
Maximum
Sep 2021
2.521B
Average
2.477B
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 137.21B |
| BioVie Inc | 14.00M |
| Autolus Therapeutics PLC | 263.91M |
| Moderna Inc | 4.572B |
| Novavax Inc | 2.514B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.43B |
| Shareholders Equity (Quarterly) | 22.38B |
| Debt to Equity Ratio | 0.0108 |
| Current Ratio | 9.431 |
| Net Debt Paydown Yield | 0.02% |